Drugs / MNC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03795974 | Jul 2017 → Oct 2019 | spastic cerebral palsy | Tehran University of Medical Sciences | Unknown | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03795974 ↗ |